Literature DB >> 16313999

Twenty-year secular changes in sex specific lung cancer incidence rates in an urban Chinese population.

Kexin Chen1, Peizhong Peter Wang, Baocun Sun, Qiang Li, Anthony Perruccio, Denise Power, Changli Wang, Min He, He M, Yu Shibei, Murray Krahn, Angela Cheung, Xishan Hao.   

Abstract

The objective of this study was to describe trends in the incidence rates of primary lung cancer in a geographically defined Chinese population. Primary lung cancer cases (N=40,022) diagnosed between 1981 and 2000 were identified by the Tianjin Cancer Registry. Age-specific and age-adjusted incidence rates to the world standard population were examined in both males and females. Age-period-cohort (APC) model and Poisson regression were used to assess the cohort effects and incidence trends. Crude and age-adjusted incidence rates in the study period were: 66.2/100,000 and 45.2/100,000 in males; and 47.7/100,000 and 28.2/100,000 in females, respectively. The major birth cohort effect can be described as for those born before 1940, in every age group lung cancer incidence rate increased as the birth years advanced. For those born after 1940, age specific incidence rates decreased as the birth years advanced. Results from the Poisson regression analyses suggested a statistically significant increasing trend of incidence rates of lung cancer from 1981 to 1990 and changed little afterwards. Through first 10 years of the study period between 1981 and 2000, lung cancer incidence rates increased in both males and females. While the study results suggest that the age-adjusted incidence rates may have reached their peak and may even decline, as the Chinese population ages, and smoking prevalence remains high, the number of new lung cancer cases will continue to increase and overall burden of lung cancer will remain high.

Entities:  

Mesh:

Year:  2005        PMID: 16313999     DOI: 10.1016/j.lungcan.2005.08.013

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  8 in total

1.  AGTR1 promoter hypermethylation in lung squamous cell carcinoma but not in lung adenocarcinoma.

Authors:  Ruhua Chen; Qingxiao Hong; Jianzhong Jiang; Xiaoying Chen; Zhenhuan Jiang; Jinzhi Wang; Shunlin Liu; Shiwei Duan; Shunbin Shi
Journal:  Oncol Lett       Date:  2017-08-25       Impact factor: 2.967

Review 2.  Outcome of advanced NSCLC patients harboring sensitizing EGFR mutations randomized to EGFR tyrosine kinase inhibitors or chemotherapy as first-line treatment: a meta-analysis.

Authors:  E Bria; M Milella; F Cuppone; S Novello; A Ceribelli; V Vaccaro; I Sperduti; A Gelibter; G V Scagliotti; F Cognetti; D Giannarelli
Journal:  Ann Oncol       Date:  2011-02-16       Impact factor: 32.976

Review 3.  Epidemiology of lung cancer.

Authors:  Carole A Ridge; Aoife M McErlean; Michelle S Ginsberg
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

4.  Impacts of thyroxine combined with donepezil on hippocampal ultrastructures and expressions of synaptotagmin-1 and SNAP-25 in adult rats with hypothyroidism.

Authors:  Hao Yang; Xiaoxue Zha; Yaojun Cai; Fen Wang; Zhangbi Wu; Bo Wu; Xuemei Jia; Defa Zhu
Journal:  Int J Clin Exp Med       Date:  2015-10-15

5.  Lung cancer: changes in histology, gender, and age over the last 30 years in Brazil.

Authors:  Maria Teresa Ruiz Tsukazan; Álvaro Vigo; Vinícius Duval da Silva; Carlos Henrique Barrios; Jayme de Oliveira Rios; José Antônio de Figueiredo Pinto
Journal:  J Bras Pneumol       Date:  2017 Sep-Oct       Impact factor: 2.624

6.  [Comparative analysis of clinical epidemiology and pathological characteristics of 908 patients with primary lung cancer of Hunan Province in 1997 and 2007].

Authors:  Fang Li; Li Huang; Chengping Hu; Qihua Gu; Xiaoxia Zhu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2010-04

Review 7.  [Gender-associated differences of lung cancer and mechanism].

Authors:  Xin Xing; Yongde Liao; Hexiao Tang; Guang Chen; Sheng Ju; Liangkun You
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2011-07

8.  Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib.

Authors:  Yanhong Shang; Xiaofang Li; Weiwei Liu; Xiaoliang Shi; Shaohua Yuan; Ran Huo; Guotao Fang; Xiao Han; Jingnan Zhang; Kunjie Wang; Zhengyue Dou; Yan Zhang; Aimin Zang; Lin Zhang
Journal:  Sci Rep       Date:  2020-11-20       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.